People
Our people are our most valuable asset and their quality, creativity, and dedication are indispensable to our success.
Search People
Latest News About Our People
April 20, 2026
Deals and Wins
Foley Advises EpiVax in Acquisition by SV Health Investors
Foley & Lardner LLP served as legal advisor to EpiVax Inc., a leading bioanalytical contract research organization specializing in immunogenicity risk assessments for pharmaceutical and biotech companies, in its acquisition by SV Health Investors, a health care and life sciences focused private investment firm.
April 17, 2026
In the News
Foley Moves Up to No. 43 on 2026 Am Law 100 List
Foley & Lardner LLP moved up two spots and is ranked as the No. 43 highest-grossing law firm on the 2026 Am Law 100, an annual report assessing the financial performance of the largest law firms in the United States.
April 16, 2026
Press Releases
Foley Announces Jennifer Walsh and Katie Schoettler as New Federal Lobbying Team Leadership
Foley & Lardner LLP is pleased to announce new leadership appointments for its Federal Lobbying team within the firm’s Government Solutions Practice Group, naming public affairs directors Jennifer Walsh as chair and Katie Schoettler as vice chair.